Group 1 - The core viewpoint of the article highlights the significant increase in southbound capital holdings in Jinxin Reproductive Medicine (01951.HK), with a net increase of 1,745,250 shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net reductions in southbound capital holdings, totaling a decrease of 13,433,500 shares [1] - As of now, southbound capital holds 1.454 billion shares of Jinxin Reproductive Medicine, accounting for 52.73% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, ambulatory surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [1] - The company's services are mainly provided in China and the United States [1]
锦欣生殖（01951.HK）：1月23日南向资金增持91.45万股